| TTM
|
9/30/2025
|
9/30/2024
|
9/30/2023
|
9/30/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
81,666 | 79,364 | 101,214 | 113,315 | 106,298 |
| Cost of Revenue
|
-43,396 | -52,381 | -64,983 | -77,763 | -66,787 |
|
Gross Profit
|
38,270 | 26,983 | 36,231 | 35,552 | 39,511 |
|
Selling, General and Administrative Expenses
|
-28,432 | -28,951 | -33,814 | -42,002 | -28,300 |
|
Research and Development Expenses
|
-3,097 | -2,649 | -4,193 | -7,311 | -6,390 |
|
Operating Income/Expenses
|
-31,529 | -31,600 | -38,007 | -49,313 | -34,690 |
|
Total Operating Profit/Loss
|
6,741 | -4,617 | -1,776 | -13,761 | 4,821 |
| Total Net Finance Income/Expense
|
599 | 213 | -500 | -154 | 46 |
| Net Investment Income
|
-934 | 199 | -345 | -89 | 1,066 |
| Irregular Income/Expenses
|
-125 | -23,871 | -4,953 | -1,209 | 12,465 |
|
Other Income/Expense, Non-Operating
|
236 | 84 | 63 | 31 | 387 |
|
Non-Operating Income/Expenses, Total
|
-224 | -23,375 | -5,735 | -1,421 | 13,964 |
|
Pretax Income
|
6,517 | -27,992 | -7,511 | -15,182 | 18,785 |
|
Provision for Income Tax
|
-2,517 | -2,334 | -975 | 2,600 | -1,418 |
|
Net Income from Continuing Operations
|
4,000 | -30,326 | -8,486 | -12,582 | 17,367 |
|
Discontinued Operations
|
-- | -- | -- | -- | 0 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
4,000 | -30,326 | -8,486 | -12,582 | 17,367 |
|
Net Income after Non-Controlling/Minority Interests
|
4,000 | -30,326 | -8,486 | -12,582 | 17,367 |
|
Net Income Available to Common Stockholders
|
4,000 | -30,326 | -8,486 | -12,582 | 17,367 |
|
Diluted Net Income Available to Common Stockholders
|
4,000 | -30,326 | -8,486 | -12,582 | 17,367 |
| Basic EPS
|
0.28 | -2.12 | -0.60 | -0.89 | 1.24 |
| Diluted EPS
|
0.27 | -2.12 | -0.60 | -0.89 | 1.22 |
|
Basic Weighted Average Shares Outstanding
|
14,639.50 | 14,302 | 14,208 | 14,065 | 14,014 |
|
Diluted Weighted Average Shares Outstanding
|
15,029.50 | 14,302 | 14,208 | 14,065 | 14,184 |
|
Reported Normalized Diluted EPS
|
0.38 | 0.05 | 0.00 | -0.02 | 0.38 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
5,918 | -28,205 | -7,011 | -15,028 | 18,739 |
|
EBITDA
|
8,354 | -25,463 | -3,982 | -10,016 | 20,468 |
|
Normalized EBITDA
|
9,902 | 5,375 | 4,029 | -270 | 8,648 |
|
Normalized Income
|
5,654 | 781 | 43 | -262 | 5,445 |
9/30/2022 - 8/9/1983
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade